Paralel Advisors LLC Buys New Shares in Humana Inc. $HUM

Paralel Advisors LLC purchased a new stake in Humana Inc. (NYSE:HUM) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,322 shares of the insurance provider’s stock, valued at approximately $5,292,000. Humana accounts for about 0.2% of Paralel Advisors LLC’s investment portfolio, making the stock its 23rd largest position.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Montag A & Associates Inc. lifted its stake in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. Johnson Financial Group Inc. acquired a new stake in Humana during the second quarter worth about $26,000. Fideuram Asset Management Ireland dac bought a new position in Humana during the fourth quarter valued at about $27,000. Trust Co. of Vermont bought a new position in Humana during the second quarter valued at about $28,000. Finally, Reflection Asset Management acquired a new position in Humana in the 4th quarter valued at approximately $29,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Up 0.7%

HUM stock opened at $380.48 on Friday. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The firm has a market cap of $45.69 billion, a P/E ratio of 36.00, a P/E/G ratio of 2.16 and a beta of 0.72. The business’s 50 day moving average is $383.38 and its 200-day moving average is $280.90. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.Humana’s revenue was up 26.2% on a year-over-year basis. During the same quarter last year, the company earned $6.27 EPS. Equities analysts anticipate that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on HUM shares. Guggenheim raised their price objective on Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 target price for the company in a research note on Wednesday, July 29th. Morgan Stanley raised Humana from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $249.00 to $370.00 in a research report on Tuesday, August 4th. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target on the stock in a research note on Thursday, July 30th. Finally, William Blair began coverage on shares of Humana in a report on Wednesday, May 20th. They issued an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $395.22.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.